A Safety and Efficacy Study of LiRIS® in Females With Interstitial Cystitis With Hunner's Lesions

Study Identifier
201025-001
CT.gov Identifier
NCT02395042
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Protocol
Available Language(s): English
Download document(s)
Statistical Analysis Plan
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Bladder Disorder - Interstitial Cystitis
  • Other
    • Study Drug
  • LiRIS®
  • LiRIS Placebo
    • Phase
    Phase 2
    Sex
    Female
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Diagnosis of interstitial cystitis with Hunner's lesions/ulcers
    Exclusion Criteria:
    * Previous treatment with LiRIS® * Interstitial cystitis/bladder pain syndrome, without Hunner's lesions/ulcers

    Protocol Summary

    This is a safety and efficacy study of LiRIS® in females with interstitial cystitis with Hunner's lesions.

    Study Locations

    Location
    Status
    Location
    Tri Valley Urology Medical Group
    Murrieta, California, United States, 92562
    Status
    Not applicable
    Location
    Sutter Institute for Medical Research
    Vacaville, California, United States, 95688
    Status
    Not applicable
    Location
    Women's Health Specialty Care
    Farmington, Connecticut, United States, 06032
    Status
    Not applicable
    Location
    Atlanta Medical Research Institute
    Alpharetta, Georgia, United States, 30005
    Status
    Not applicable
    Location
    Anne Arundel Urology, P.A.
    Annapolis, Maryland, United States, 21401
    Status
    Not applicable
    Location
    Chesapeake Urology Research Associates
    Baltimore, Maryland, United States, 21237
    Status
    Not applicable
    Showing {first} - {last} of {total} Results